Product References
Ultrasound combined with nanobubbles promotes systemic anticancer immunity and augments anti-PD1 efficacy.
Journal for immunotherapy of cancer
Hu J,He J,Wang Y,Zhao Y,Fang K,Dong Y,Chen Y,Zhang Y,Zhang C,Wang H,Tan J,Wang J,Zi R,Liu C,Liang H,Guo Y,Ou J
HMCD15201 was used in Flow Cytometry to provide a promising strategy for sensitizing poorly immunogenic solid tumors to immunotherapy in the clinic.
Tue Mar 01 00:00:00 UTC 2022
Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer.
Therapeutic advances in medical oncology
Doo DW,Meza-Perez S,Londoño AI,Goldsberry WN,Katre AA,Boone JD,Moore DJ,Hudson CT,Betella I,McCaw TR,Gangrade A,Bao R,Luke JJ,Yang ES,Birrer MJ,Starenki D,Cooper SJ,Buchsbaum DJ,Norian LA,Randall TD,Arend RC
Published figure using CTLA-4 monoclonal antibody (Product # HMCD15201) in Flow Cytometry
Thu Apr 14 00:00:00 UTC 2022
Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer.
Therapeutic advances in medical oncology
Doo DW,Meza-Perez S,Londoño AI,Goldsberry WN,Katre AA,Boone JD,Moore DJ,Hudson CT,Betella I,McCaw TR,Gangrade A,Bao R,Luke JJ,Yang ES,Birrer MJ,Starenki D,Cooper SJ,Buchsbaum DJ,Norian LA,Randall TD,Arend RC
Published figure using CTLA-4 monoclonal antibody (Product # HMCD15201) in Flow Cytometry
Thu Apr 14 00:00:00 UTC 2022
Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment.
Cancers
Goldsberry WN,Meza-Perez S,Londoño AI,Katre AA,Mott BT,Roane BM,Goel N,Wall JA,Cooper SJ,Norian LA,Randall TD,Birrer MJ,Arend RC
HMCD15201 was used in Flow cytometry/Cell sorting to study Wnt activity within the microenvironment of ovarian tumors.
Tue Mar 24 00:00:00 UTC 2020
Enhancement of antitumor immunity by CTLA-4 blockade.
Science (New York, N.Y.)
Leach DR,Krummel MF,Allison JP
HMCD15201 was used in blocking or activating experiment to show that administration f antibodies that recognize CTLA-4 results in rejection of tumors
Fri Mar 22 00:00:00 UTC 1996